Sumanth Gandra

2014–2025 年に発表

49
論文数
19,578
被引用数
35
h 指数
47
i10 指数

被引用数

Sumanth Gandra の年別被引用数1969 年: 被引用 1 件1980 年: 被引用 3 件1986 年: 被引用 1 件1998 年: 被引用 3 件2002 年: 被引用 1 件2004 年: 被引用 1 件2009 年: 被引用 1 件2014 年: 被引用 2 件2015 年: 被引用 29 件2016 年: 被引用 73 件2017 年: 被引用 75 件2018 年: 被引用 162 件2019 年: 被引用 772 件2020 年: 被引用 966 件2021 年: 被引用 1,130 件2022 年: 被引用 1,023 件2023 年: 被引用 925 件2024 年: 被引用 1,415 件2025 年: 被引用 729 件2026 年: 被引用 8 件1970〜1979 年は被引用が無いため表示していません1981〜1985 年は被引用が無いため表示していません1987〜1997 年は被引用が無いため表示していません1999〜2001 年は被引用が無いため表示していません2003 年は被引用が無いため表示していません2005〜2008 年は被引用が無いため表示していません2010〜2013 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,277 件、この内訳の 10.7%中国: 引用元論文 1,267 件、この内訳の 10.6%イギリス: 引用元論文 956 件、この内訳の 8%インド: 引用元論文 559 件、この内訳の 4.7%ドイツ: 引用元論文 416 件、この内訳の 3.5%イタリア: 引用元論文 402 件、この内訳の 3.4%フランス: 引用元論文 376 件、この内訳の 3.1%スペイン: 引用元論文 365 件、この内訳の 3%オーストラリア: 引用元論文 364 件、この内訳の 3%スイス: 引用元論文 301 件、この内訳の 2.5%カナダ: 引用元論文 272 件、この内訳の 2.3%南アフリカ: 引用元論文 265 件、この内訳の 2.2%
0%10.7%その他 43%

分野

  • Biochemistry, Genetics and Molecular Biology35.9%
  • Immunology and Microbiology22.8%
  • Medicine17.1%
  • Environmental Science13.9%
  • Agricultural and Biological Sciences3.2%
  • Engineering2%
  • その他5.1%

トピック

  • Antibiotic Resistance in Bacteria16.1%
  • Antibiotic Use and Resistance11.2%
  • Pharmaceutical and Antibiotic Environmental Impacts7.1%
  • Antibiotics Pharmacokinetics and Efficacy4.7%
  • Bacterial Identification and Susceptibility Testing2.8%
  • Bacterial biofilms and quorum sensing2.5%
  • その他55.6%

共著者

全論文

検索で開く
  1. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Oliver J. Dyar, Alex W. Friedrich, Ana Cristina Gales, Sumanth Gandra, Christian G. Giske, Debra A. Goff, Herman Goossens, Thomas Gottlieb, Manuel Guzmán Blanco, Waleria Hryniewicz, Deepthi Kattula, Timothy Jinks, Souha S. Kanj, Lawrence D. Kerr, Marie-Paule Kiény, Yang Soo Kim, Roman S. Kozlov, Jaime Labarca, Ramanan Laxminarayan, Karin Leder, Leonard Leibovici, Gabriel Levy-Hara, Jasper Littman, Surbhi Malhotra‐Kumar, Vikas Manchanda, Lorenzo Moja, B Ndoye, Angelo Pan, David L. Paterson, Mical Paul, Haibo Qiu, Pilar Ramón-Pardo, Jesús Rodríguez‐Baño, Maurizio Sanguinetti, Sharmila Sengupta, Mike Sharland, Massinissa Si-Mehand, Lynn L. Silver, Wonkeung Song, Martin Steinbakk, Jens Thomsen, Guy Thwaites, J W van der Meer, Nguyễn Văn Kính, Silvio Vega, María Virginia Villegas, Agnes Wechsler-Fördös, Heiman Wertheim, Evelyn Wesangula, Neil Woodford, Fidan O Yilmaz, Anna Zorzet - The Lancet Infectious Diseases 2017 被引用: 6,087

  2. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015

    著者: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 被引用: 3,187

  3. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)

    著者: , , , , , , , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2021 被引用: 995

  4. Antimicrobial resistance in low- and middle-income countries: current status and future directions

    著者: , , - Expert Review of Anti-infective Therapy 2021 被引用: 364

  5. Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis

    著者: , , , , - The Lancet Planetary Health 2018 被引用: 755

  6. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data

    著者: , , , , , , - The Lancet Infectious Diseases 2020 被引用: 502

  7. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data

    著者: , , , , , , - The Lancet Infectious Diseases 2014 被引用: 2,292

  8. The WHO AWaRe (Access, Watch, Reserve) antibiotic book and prevention of antimicrobial resistance

    著者: , , , , , , , , , , , - Bulletin of the World Health Organization 2023 被引用: 283

  9. Ultrasensitive lateral-flow assays via plasmonically active antibody-conjugated fluorescent nanoparticles

    著者: , , , , , , , , , , , , , , - Nature Biomedical Engineering 2023 被引用: 204

  10. Antibiotic prescription practices in primary care in low- and middle-income countries: A systematic review and meta-analysis

    著者: , , , , , , , , - PLoS Medicine 2020 被引用: 314

  11. Encouraging AWaRe-ness and discouraging inappropriate antibiotic use—the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2019 被引用: 255

  12. Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries

    著者: , , , , , - Clinical Microbiology Reviews 2020 被引用: 246

  13. The WHO essential medicines list AWaRe book: from a list to a quality improvement system

    著者: , , , , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2022 被引用: 126

  14. Surveillance for control of antimicrobial resistance

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maja von Cube, Cuong Vuong, Irith Wiegand, Anne Witschi, Martin Wolkewitz - The Lancet Infectious Diseases 2017 被引用: 374

  15. Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe

    著者: , , , , , , - The Lancet Infectious Diseases 2017 被引用: 328

  16. Exposure to World Health Organization's AWaRe antibiotics and isolation of multidrug resistant bacteria: a systematic review and meta-analysis

    著者: , , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2022 被引用: 179

  17. WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark Loeb - Clinical Microbiology and Infection 2024 被引用: 118

  18. Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study

    著者: , , , , - The Lancet Infectious Diseases 2015 被引用: 370

  19. The Mortality Burden of Multidrug-resistant Pathogens in India: A Retrospective, Observational Study

    著者: , , , , , , , - Clinical Infectious Diseases 2018 被引用: 225

  20. Antibiotic overuse in the primary health care setting: a secondary data analysis of standardised patient studies from India, China and Kenya

    著者: , , , , , , - BMJ Global Health 2020 被引用: 131

  21. Developing core elements and checklist items for global hospital antimicrobial stewardship programmes: a consensus approach

    著者: , , , , , , , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2018 被引用: 208

  22. The WHO AWaRe Antibiotic Book: providing guidance on optimal use and informing policy

    著者: , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2022 被引用: 62

  23. The state of the World's Antibiotics 2015.

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Wound healing 2015 被引用: 346

  24. Reducing antibiotic prescribing and addressing the global problem of antibiotic resistance by targeted hygiene in the home and everyday life settings: A position paper

    著者: , , , , , , , - American Journal of Infection Control 2020 被引用: 96